Resources

With diverse expertise and strong leadership, we empower life sciences teams with meaningful and actionable intelligence.

Aissel's KOL Mapping software built on Salesforce1 platform focuses on helping our life science customers discover and engage with the right Key Opinion Leaders. Our SFDC KOL Mapping application is an add-on to existing CRM, which can add great value to teams by providing constant customer insights. The SFDC KOL Mapping application integrates your account information with their profile information which can be accessed seamlessly without switching applications. This SFDC product brochure helps you understand the key features of the integration app and how you can enable your teams to continually be updated on their customer information.

A pacemaker is an implanted medical device that uses electrical pulses to regulate the heart's rhythm, typically by helping the heart beat at a normal rate and in the correct sync. These devices are made of a pulse generator, leads (wires), and electrodes, and are used to treat slow or irregular heartbeats, heart failure, and certain heart blocks. They can be traditional, with leads implanted through veins, or newer, smaller, leadless versions inserted through a catheter.

test

This is the testing article added for testing purpose

test

test

This is the article created for testing purpose to check that if we are selecting category as white paper

This is the article created by testing team for testing purpose

Aissel's KOL Mapping software built on Salesforce1 platform focuses on helping our life science customers discover and engage with the right Key Opinion Leaders. Our SFDC KOL Mapping application is an add-on to existing CRM, which can add great value to teams by providing constant customer insights. The SFDC KOL Mapping application integrates your account information with their profile information which can be accessed seamlessly without switching applications. This SFDC product brochure helps you understand the key features of the integration app and how you can enable your teams to continually be updated on their customer information.

A case study article which is added for testing purpose

test

desc

test test

test

test

Astellas Pharma Payments Analytics Report 2020

Teva Pharma Payments Analytics Report 2020

UCB Payments Analytics Report 2020

Teva Pharma Payments Analytics Report 2020

Amgen Payments Analytics Report 2020

Amgen Payments Analytics Report 2020

Leo Pharma Payments Analytics Report 2020

Merck Payments Analytics Report 2020

Astellas Pharma Payments Analytics Report 2020

AbbVie Payments Analytics Report 2020

Pfizer Payments Analytics Report 2020

Merck Payments Analytics Report 2020

AbbVie Payments Analytics Report 2020

Astellas Pharma Payments Analytics Report 2020

Leo Pharma Payments Analytics Report 2020

Pfizer Oncology Payments Analytics Report 2020

Puma Biotechnology Payments Analytics Report 2020

Identifying and mapping the right KOLs is the first step towards effective and impactful KOL Management. In the rapidly evolving healthcare space, life sciences companies need KOLs to create brand awareness and build credibility to their products. This Brochure helps you understand the Top 5 cutting edge and innovative features of our Software Platform and paves the way for effective KOL Management.

Aissel's KOL Mapping software built on Salesforce1 platform focuses on helping our life science customers discover and engage with the right Key Opinion Leaders. Our SFDC KOL Mapping application is an add-on to existing CRM, which can add great value to teams by providing constant customer insights. The SFDC KOL Mapping application integrates your account information with their profile information which can be accessed seamlessly without switching applications. This SFDC product brochure helps you understand the key features of the integration app and how you can enable your teams to continually be updated on their customer information.

For any drug to be commercially successful Key Opinion Leaders play a vital role to raise awareness of the brand. Hence, it becomes crucial for Life Sciences companies to engage and collaborate with influential HCPs for any drug to be popular or successful. This case study outlines how a large pharmaceutical company implemented our end to end KOL Management platform to identify the top tier and upcoming Gastroenterology experts in the United States for the commercialization of their new product.

Current HCP Development and Engagement is not just about identifying the top tier HCPs but also to identify forward-thinking experts who may not have reached a high level of visibility, but there is already a buzz around them. The standard process of identification will help in mapping out the global and national HCPs but may miss a major chunk of the regional influencers who should have been part of the target list. This document illustrates how a top Pharmaceutical company identified the local and regional Healthcare Professionals in Oncology space through our AI-powered konectar HCP Management platform.

The healthcare landscape is rapidly growing, driven by technological advancement. It is important for the healthcare industry to communicate the latest developments, scientific breakthroughs, and discovery of newer therapies to the scientific community-thus making an impact on the knowledge of the community. This white paper analyses how life sciences companies can use Social Media as an effective platform to directly communicate with patients and show the value of their companies products and show how Social media platform offers an advantage over older data collecting methods with reduced cost and the ease of access.

konectar Oncology Platform – your resource to Discover, Profile and Engage the right Oncology Experts. konectar Oncology gives you access to over 70,000 Oncology Experts carefully curated from millions of data points. The platform empowers you with rich data that is accurately curated and provides intelligence on various dimensions like speaking engagements, affiliations, publishing and research activities, industry payments details, influencer network and many more.

Pfizer is one of the world's premier innovative biopharmaceutical companies, discovering, developing and providing over 160 different medicines, vaccines and consumer healthcare products to help improve the lives of millions of people around the world. Pfizer focuses on areas that include Anti-Infectives, Inflammation & Immunology, Internal Medicine, Oncology, Rare Diseases and Vaccines.

Alexion is a global biopharmaceutical company focused on serving patients and families affected by rare diseases through the discovery, development and commercialization of life-changing therapies. Alexion develops products across different therapeutic areas including hematology, nephrology, neurology and metabolic disorders.

Gilead Sciences is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. Gilead's portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions.

Stryker is one of the world’s leading medical technology companies is driven to make healthcare better. Stryker is developing innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.

Incyte Corporation is a leading global biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. With a primary Therapeutic area focus on Oncology, rigorous science is at the core of everything Incyte does to discover, develop, and deliver novel medicines that will meet serious unmet medical needs in cancer and other diseases.

Bayer is a global enterprise with core competencies in health care and agriculture. Bayer specializes in Cardiovascular diseases, Oncology, Gynecology, Ophthalmology and Hemophilia, and offers innovative solutions with the philosophy of science for a better life.

Teva Pharmaceutical Industries is a global leader in generic medicines, with innovative treatments in select areas, including CNS, pain and respiratory. Teva delivers high-quality generic products and medicines in nearly every therapeutic area to address unmet patient needs. Headquartered in Israel, with production and research facilities around the globe, Teva is committed to improving the lives of millions of patients.

NuVasive is a leader in spine technology innovation, focused on transforming spine surgery and beyond with minimally disruptive, procedurally-integrated solutions designed to deliver reproducible and clinically-proven surgical outcomes. The Company's portfolio includes access instruments, implantable hardware, biologics, software systems for surgical planning, navigation and imaging solutions, magnetically adjustable implant systems for spine and orthopedics, and intraoperative monitoring service offerings.

Biogen is an American multinational biotechnology company specializing in the discovery, development, and delivery of worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases. Major focus areas include Multiple Sclerosis, Alzheimer’s Disease, Parkinson’s Disease, Amyotrophic Lateral Sclerosis (ALS), Spinal Muscular Atrophy (SMA) and Progressive Supranuclear Palsy (PSP).

Allergan is a global pharmaceutical company and a leader in Growth Pharma. Allergan is focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world. Allergan develops products for the central nervous system, eye care, medical aesthetics and dermatology, gastroenterology, women's health, urology and anti-infective therapeutic categories.

Alkermes is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (CNS) diseases. The company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis.

Boston Scientific, a global medical technology leader, manufactures medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.

Merck, a leading global biopharmaceutical company, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases. Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer’s disease and infectious diseases including HIV and Ebola.

Celgene Corporation is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of innovative therapies for the treatment of cancer and inflammatory diseases through next-generation solutions in protein homeostasis, immuno-oncology, epigenetics, immunology and neuro-inflammation. Celgene’s commercial stage products and the depth of our product pipeline, provide the catalysts for future growth.

Amgen is a biopharmaceutical company committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. Amgen focuses on areas that include Bone Health, Cardiovascular, Hematology/Oncology, Inflammation and Neuroscience. </br> In 2017, Amgen spent $7,144,971 on 10,850 Oncology experts for General Payments. This White Paper provides insights on Amgen Industry-HCP Partnerships (2013-2017). The information is sourced from Open Payments as mandated by The Physician Payments Sunshine Act.

Allergan is a global pharmaceutical company and a leader in Growth Pharma. Allergan is focused on developing, manufacturing and commercialising branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world. Allergan develops products for the central nervous system, eye care, medical aesthetics and dermatology, gastroenterology, women's health, urology and anti-infective therapeutic categories.

AbbVie is a global, research and development-based biopharmaceutical company committed to developing innovative advanced therapies for some of the world's most complex and critical conditions. AbbVie develops products across four primary therapeutic areas: immunology, oncology, virology and neuroscience.

Healthcare Professionals have an extremely close knit community, where they constantly look up to their peers and more experienced HCPs for guidelines on clinical practices. While most national influencers who are prolific speakers and well published are generally known in the community, local influencers are hard to identify. This case study analyses the challenges of life sciences companies in identifying regional and local influencers and provides strategies that can be implemented to identify high-value practice leaders and local influencers without increasing costs.